mAbsolve Ltd.
PrivateLast Round
Seed
Mar 3, 2020
Total Funding Raised
$179,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
mAbsolve Ltd. is a biotechnology company that develops and licenses its proprietary STR Fc silencing technology to improve the safety and effectiveness of therapeutic antibodies and Fc fusion proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mAbsolve Ltd. Comparables
Compare mAbsolve Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CROSSPOINT Therapeutics | 86% | |
| AbFinder Therapeutics Co., Ltd. | 65% | |
| Vector Laboratories | 64% | |
mAbsolve Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 3, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 162% MoM, reaching 2.5K.
- Nov 9, 2025
Monthly visitors increased 122% MoM.
mAbsolve Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mAbsolve Ltd.'s valuation, stock price, and market status.